Clinical Trials
All Clinical Trials - Page 74 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT00004327Phase 2Completed
Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia
Octreotide
- NCT00461149Phase 4Completed
Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly
Octreotide
- NCT00002597Phase 3Completed
Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
Gonadorelin
- NCT00004426N/ACompleted
Leuprolide in Determining the Cause of Gonadotropin Deficiency
Gonadorelin
- NCT00001322Phase 1/Phase 2Completed
The Effects of Reproductive Hormones on Mood and Behavior
Gonadorelin
- NCT00227253N/ARecruiting
Chromosome 18 Clinical Research Center
Gonadorelin
- NCT00004436N/ACompleted
Randomized Study of Hormonal Regulation of Infantile Hemangioma
Gonadorelin
- NCT00002580Phase 3Completed
Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer
Gonadorelin
- NCT00004332N/ACompleted
Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly
Sermorelin
- NCT00004763Phase 2Completed
Phase II Randomized Study of Leuprolide Vs Oral Contraceptive Therapy Vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism
Gonadorelin
- NCT00004771Phase 2Completed
Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron Disease
Gonadorelin
- NCT00660010Phase 3Completed
Study of Lupron Depot In The Treatment of Central Precocious Puberty
Gonadorelin
- NCT00309478Phase 3Completed
Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients
Gonadorelin
- NCT01819285Phase 3Completed
Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer
Gonadorelin
- NCT00004311Phase 2Completed
Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome
Gonadorelin
- NCT00001228Phase 2Completed
Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer
Octreotide
- NCT00002460Phase 3Unknown
Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer
Gonadorelin
- NCT00005006Phase 2Completed
Parathyroid Hormone (PTH) With Alendronate for Osteoporosis
Teriparatide
- NCT00001190Phase 2Completed
Study of Luteinizing Hormone-Releasing Hormone Analog (LHRHa) in Pubertal Patients With Extreme Short Stature
Gonadorelin
- NCT07629401N/AAvailable
Pre-approval Expanded Access of Retatrutide (LY3437943)
Retatrutide
- NCT00082082Phase 2Completed
A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma
Thymosin-Alpha-1
- NCT00001036Phase 1Completed
The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of Infection
Thymosin-Alpha-1
- NCT04689360N/AAvailable
An Intermediate Size Expanded Access Protocol of Elamipretide
Elamipretide
- NCT00505817Phase 4Completed
GnRH Agonist and Antagonists in an Oocyte Donation Program
Gonadorelin
- NCT00000325Phase 1Completed
Psychostimulant Abuse - Novel Treatment Approaches - 1
Gonadorelin
- NCT02065323Phase 2Withdrawn
A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT
Gonadorelin
- NCT01629420Phase 2Completed
A Phase II Randomized Open Label Study of KLH-2109 in Patients With Endometriosis
Gonadorelin
- NCT00669786Phase 3Completed
Human Menopausal Gonadotropin (HMG) vs Recombinant Follicle Stimulating Hormone (rFSH) in Gonadotropin Releasing Hormone (GnRH) Antagonist Cycles
Gonadorelin
- NCT00888082Phase 3Withdrawn
Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy
Gonadorelin
- NCT05183802N/AApproved For Marketing
An Expanded Access Protocol for Setmelanotide for Treatment of Bardet-Biedl Syndrome (BBS)
Setmelanotide
- NCT00046137Phase 3Completed
Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis
Teriparatide
- NCT02223416Phase 1Completed
A Study Aimed at Assessing the Pharmacokinetic Properties of RGB-10 and Forsteo
Teriparatide
- NCT00227773Phase 2Withdrawn
Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors
Octreotide
- NCT02217826Phase 1Completed
Single Dose Pharmacodynamic and Pharmacokinetic Study of DG3173
Octreotide
- NCT00002253N/ACompleted
A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either "Responders" or "Non-Responders" in a Prior Placebo-Controlled Double-Blind Sandostatin Study.
Octreotide
- NCT00002252N/ACompleted
A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea
Octreotide
- NCT00916916N/AUnknown
Lanreotide Levels in Acromegaly
Lanreotide